{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:29:50Z","timestamp":1784194190161,"version":"3.55.0"},"reference-count":17,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,11,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>Varicella-zoster virus has been reported to produce serious, often life-threatening, disease in immunosuppressed patients with a variety of diagnoses. The impact of this virus on the young child after heart transplantation has not been reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We reviewed the charts of 28 children who were &amp;lt;10 years of age at heart transplantation and had at least 1 year of follow-up. The median follow-up period was 7 years (1.4\u201313.0 years). All were seronegative for varicella-zoster virus before transplantation. Fourteen (50%) developed varicella at a median time posttransplantation of 3.3 years. The first 7 were admitted for intravenous acyclovir for 3 days followed by oral acyclovir for 7 days. The last 7 were treated as outpatients with oral valacyclovir for 7 days (n = 6) or with oral acyclovir for 10 days (n = 1).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Intravenous and oral regimens both were well tolerated and were without complications. No patient was receiving steroids at the time that they developed their initial episode of varicella. One patient was receiving steroids for therapy of posttransplantation lymphoproliferative disease when she developed recurrent varicella or generalized zoster. No episodes of rejection were attributed to the varicella-zoster virus infection. There were no episodes of localized zoster. All patients experienced seroconversion from undetectable to detectable antibody titers early after varicella, and 12 of the 14 patients continued to have persistent detectable titers in late follow-up. Two of the 14 who received chemotherapy or enhanced immunosuppression after retransplantation transiently lost detectable varicella-zoster virus antibodies but currently have detectable titers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions.<\/jats:title><jats:p>Primary varicella-zoster infection was well tolerated in our young pediatric heart transplant recipients, with no serious complications. We now reserve inpatient\/intravenous therapy for those who are unable to tolerate oral medications or those who are receiving enhanced immunosuppression.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.108.5.e80","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"e80-e80","source":"Crossref","is-referenced-by-count":13,"title":["Varicella in a Pediatric Heart Transplant Population on Nonsteroid Maintenance Immunosuppression"],"prefix":"10.1542","volume":"108","author":[{"given":"Debra A.","family":"Dodd","sequence":"first","affiliation":[{"name":"From the Department of Pediatrics, Division of Pediatric Cardiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Burger","sequence":"additional","affiliation":[{"name":"From the Department of Pediatrics, Division of Pediatric Cardiology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"Division of Pediatric Infectious Disease, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Stephen","family":"Dummer","sequence":"additional","affiliation":[{"name":"Department of Medicine\/Infectious Disease, Vanderbilt University School of Medicine, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,11,1]]},"reference":[{"key":"2021121003521758800_B1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/106002809703100211","article-title":"Valacyclovir.","volume":"31","author":"Acosta","year":"1997","journal-title":"Ann Pharmacother"},{"key":"2021121003521758800_B2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/AAC.44.1.207-209.2000","article-title":"Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukemia after chemotherapy.","volume":"44","author":"Steingrimsdottir","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2021121003521758800_B3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00006454-198411000-00004","article-title":"Varicella: clinical manifestations, epidemiology and health impact on children.","volume":"3","author":"Preblud","year":"1984","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003521758800_B4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1542\/peds.56.3.388","article-title":"Varicella in children with cancer: seventy-seven cases.","volume":"56","author":"Feldman","year":"1975","journal-title":"Pediatrics"},{"key":"2021121003521758800_B5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-3476(81)80527-6","article-title":"Varicella in children with renal transplants.","volume":"98","author":"Feldhoff","year":"1981","journal-title":"J Pediatr"},{"key":"2021121003521758800_B6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0022-3476(82)80725-7","article-title":"Acyclovir therapy of chickenpox in immunosuppressed children: a collaborative study.","volume":"101","author":"Prober","year":"1982","journal-title":"J Pediatr"},{"key":"2021121003521758800_B7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1542\/peds.80.4.465","article-title":"Varicella in children with cancer: impact of antiviral therapy and prophylaxis.","volume":"80","author":"Feldman","year":"1987","journal-title":"Pediatrics"},{"key":"2021121003521758800_B8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0022-3476(97)70036-2","article-title":"Outcome of chickenpox in 66 pediatric renal transplant recipients.","volume":"131","author":"Kashtan","year":"1997","journal-title":"J Pediatr"},{"key":"2021121003521758800_B9","first-page":"37","article-title":"Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).","volume":"1","author":"Furth","year":"1997","journal-title":"Pediatr Transplant"},{"key":"2021121003521758800_B10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/978-1-4615-4743-3_14","article-title":"Valaciclovir update.","volume":"458","author":"Bell","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"2021121003521758800_B11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1542\/peds.99.1.35","article-title":"Varicella and zoster in children after kidney transplantation: long-term results of vaccination.","volume":"99","author":"Broyer","year":"1997","journal-title":"Pediatrics"},{"key":"2021121003521758800_B12"},{"key":"2021121003521758800_B13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00865476","article-title":"Attenuated varicella virus vaccine in children with renal transplants.","volume":"8","author":"Zamora","year":"1994","journal-title":"Pediatr Nephrol"},{"key":"2021121003521758800_B14","first-page":"3296","article-title":"Varicella Zoster in a transplant program: experience with 15 cases and 70 contacts.","volume":"28","author":"Zayas","year":"1996","journal-title":"Transplant Proc"},{"key":"2021121003521758800_B15"},{"key":"2021121003521758800_B16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/infdis\/167.1.195","article-title":"Immune responses to varicella zoster virus infections in healthy children.","volume":"167","author":"Rotbart","year":"1993","journal-title":"J Infect Dis"},{"key":"2021121003521758800_B17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/infdis\/171.5.1383","article-title":"Immune response to varicella-zoster virus 5 years after acyclovir therapy in childhood varicella.","volume":"171","author":"Levin","year":"1995","journal-title":"J Infect Dis"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/5\/e80\/892801\/pe1101000ji1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/5\/e80\/892801\/pe1101000ji1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:31:52Z","timestamp":1682746312000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/108\/5\/e80\/63680\/Varicella-in-a-Pediatric-Heart-Transplant"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2001,11,1]]},"published-print":{"date-parts":[[2001,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.108.5.e80","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11,1]]}}}